Project

A Multicenter Phase III Randomized study with second line chemotherapy plus or minus Bevacizumab in patients with Plati-num sensitive Epithelial ovarian cancer recurrence after a Bevacizumab/chemotherapy first line

Automatically Closed · 2014 until 2016

Weder Patrik, Hasler-Strub Ursula, Riniker Salome, Diem Stefan, Ruhstaller Thomas